www.BillionPhotos.com / Shutterstock.com
A unitary supplementary protection certificate looks like a logical and desirable extension of the unitary patent system, and right owners and practitioners need to keep an eye on developments in EU regulation, as Andrew Webb and Graham Lewis of J A Kemp describe.
A supplementary protection certificate (SPC) can give up to five extra years of exclusivity after a patent has expired. SPCs are available in many European countries for active ingredients of human and veterinary medicinal products and plant protection products that require marketing authorisation. They were introduced to compensate patent owners whose effective patent term was eroded by delays in receiving marketing authorisation.
To qualify for SPC protection, there must be a valid authorisation to market the product in that country. In addition, an active ingredient of the product must be protected by a patent in force in the country of interest. Although a separate right, an SPC remains linked to the patent on which it is based. If the patent is revoked or surrendered, the SPC also lapses.
This raises some interesting questions regarding the interaction of SPCs with the upcoming unitary patent and concurrent Unified Patent Court (UPC) system.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
Andrew Webb, Graham Lewis, J A Kemp, CJEU, SPCs, patent, regulation, UPC, European patent, UPC system, plant protection,